APA (7th ed.) Citation

M, K., P, G., K, O., S, G., L, S., P, K., & J, C. (2026). Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer. Clinical lung cancer, 27(6), 11. https://doi.org/10.1016/j.cllc.2026.05.001

Chicago Style (17th ed.) Citation

M, Kilpatrick, Gundersen P, O'Reilly K, Goyal S, Sun L, Kim P, and Carlisle J. "Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer." Clinical Lung Cancer 27, no. 6 (2026): 11. https://doi.org/10.1016/j.cllc.2026.05.001.

MLA (9th ed.) Citation

M, Kilpatrick, et al. "Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer." Clinical Lung Cancer, vol. 27, no. 6, 2026, p. 11, https://doi.org/10.1016/j.cllc.2026.05.001.